• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Medical Aesthetics Market

    ID: MRFR/HC/11121-HCR
    128 Pages
    Rahul Gotadki
    September 2025

    US Medical Aesthetics Market Research Report Information By Product (Facial Aesthetic Products, Cosmetics Implant, Skin Aesthetic Devices, Body Contouring Devices, Physician-dispensed Cosmeceuticals and Skin Lighteners, Hair Removal Devices, Tattoo Removal Devices, Thread Lift Products, Physician-dispensed Eyelash Products, and Nail Treatment Laser Devices), By Procedure (Surgical Procedures (Breast Augmentation, Rhinoplasty, Facelift and Body Lift, Other Surgical Procedures), and Non-Surgical Procedures (Anti-Aging and Skin Rejuvenation, Ta...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Medical Aesthetics Market Research Report—Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    US Medical Aesthetics Market Summary

    The US Medical Aesthetics market is projected to grow significantly from 2.91 billion USD in 2024 to 6.65 billion USD by 2035.

    Key Market Trends & Highlights

    US Medical Aesthetics Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 7.81 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 6.65 billion USD, indicating robust growth potential.
    • In 2024, the market is valued at 2.91 billion USD, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced aesthetic technologies due to increasing consumer demand for non-invasive procedures is a major market driver.

    Market Size & Forecast

    2024 Market Size 2.91 (USD Billion)
    2035 Market Size 6.65 (USD Billion)
    CAGR (2025-2035) 7.81%

    Major Players

    AbbVie, Cynosure, Evolus Inc., Revance Therapeutics, Inc, Galderma, Lumenis, Solta Medical, Syneron Candela, Alma Laser

    US Medical Aesthetics Market Trends

    Increase in the popularity of non-invasive and minimally invasive cosmetic procedures is driving the market growth

    Cosmetic medicine is seeing an increase in minimally invasive and non-surgical aesthetic procedures, which provide a practical and less dangerous substitute for conventional surgery. These procedures, which include chemical peels, microdermabrasion, laser therapy, dermal fillers, and Botox, address a variety of aesthetic issues with outcomes that seem natural. Their simplicity in recuperation and easy resumption of everyday activities stems from their minimal downtime. Furthermore, their adaptability and configurable features are making them more and more popular with people of all ages.

    For example, the Plastic Surgery Statistics Report 2020 from the American Society of Plastic Surgeons states that 6.8 million reconstructive treatments, 13.2 million cosmetic minimally invasive procedures, and 2.3 million cosmetic surgical procedures were carried out in the US in 2020. Significantly, these therapies reduce scarring, which makes them the therapy of choice for people who are worried about surgical scars. For safe and successful results, nevertheless, only licensed medical professionals should carry out these procedures, and for individualized treatment regimens, communication with healthcare providers is essential.

    Plastic surgery, breast implants, injection therapy for botulinum toxin, and other anti-aging goods and treatments have been made possible by technological advancements and large investments in research and development. The potential for growth in the anti-aging market has been increased by producers introducing safer and more effective treatments due to strict rules and regulations. Furthermore, specialized businesses have made high-end anti-aging products more accessible and available, despite the fact that department stores have always carried them. These days, these goods are sold through speciality retail stores, infomercials, home shopping channels, salons, spas, and internet sellers.

    Thus, driving the US Medical Aesthetics Market revenue.

    Market Segment Insights

    US Medical Aesthetics Product Insights

    The US Medical Aesthetics Market segmentation, based on product includes Facial Aesthetic Products, Cosmetics Implant, Skin Aesthetic Devices, Body Contouring Devices, Physician-dispensed Cosmeceuticals and Skin Lighteners, Hair Removal Devices, Tattoo Removal Devices, Thread Lift Products, Physical-Dispensed Eyelash Products, and Nail Treatment Laser Devices. The facial aesthetic products segment dominated the market mostly because more and more women are choosing to work, having more money to spend, and wanting to look young, attractive, and get the best possible treatment.

    Additionally, the segment's growth is expected to be influenced by the growing demand for derma filers because of their advantageous applications, which include reducing the look of sunken scars, softening facial creases and wrinkles, boosting shallow contours, and plumping thin lips.

    US Medical Aesthetics Procedure Insights

    The US Medical Aesthetics Market segmentation, based on procedure, includes Surgical Procedures (Breast Augmentation, Rhinoplasty, Facelift and Body Lift, Other Surgical Procedures), and Non-Surgical Procedures (Anti-Aging and Skin Rejuvenation, Tattoo and Scar Removal, Hair Removal, Lipolysis, and Other Non-Surgical Procedures. The non-surgical procedures category generated the most income. Some of the elements that have increased demand for non-invasive procedures include less pain, quick outcomes, and low cost. Nutraceuticals, soft tissue fillers, and chemical peels are popular non-invasive procedures.

    US Medical Aesthetics End User Insights

    The US Medical Aesthetics Market segmentation, based on end user, includes Clinics, Hospitals, and Medical Spas, Beauty Centers, and Home Care Settings. The clinics, hospitals, and medical spas category generated the most income because of a variety of factors, including the easier availability to material and financial resources at clinics and hospitals, including skilled surgeons and more. Furthermore, developments in medical aesthetic procedures are readily available and deliverable in hospitals and clinics, which supports segment expansion.

    Figure 1: US Medical Aesthetics Market, by End User, 2022 & 2032 (USD Billion)

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Get more detailed insights about US Medical Aesthetics Market Research Report—Forecast till 2032

    Regional Insights

    The US Medical Aesthetics Market area will grow at a significant rate as a result of the large number of cosmetic procedures carried out, the aging population, more disposable income, greater awareness, and government support for the infrastructure of healthcare. The region's robust research pipeline, the development of high-tech products, and the FDA's approval of aesthetic devices for home use are all contributing factors to the growing demand for US Medical Aesthetics. Additionally, a variety of market participants in this nation contribute to the industry's growth.

    The market is expected to grow even faster as long as major players in the country continue to meet the high and rising demand.

    Key Players and Competitive Insights

    Leading market players are investing heavily in research and development in order to expand their product lines, which will help the US Medical Aesthetics Market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, US Medical Aesthetics industry must offer cost-effective items.

    Key Companies in the US Medical Aesthetics Market market include

    Industry Developments

    • Q2 2024: Allergan Aesthetics Announces FDA Approval of Skinvive™ by JUVÉDERM® for the Improvement of Cheek Skin Smoothness in Adults Allergan Aesthetics, an AbbVie company, received FDA approval for Skinvive™ by JUVÉDERM®, a hyaluronic acid intradermal microdroplet injection, for improving cheek skin smoothness in adults.
    • Q2 2024: Crown Aesthetics Announces FDA Clearance of SkinPen® Precision for the Treatment of Neck Wrinkles Crown Aesthetics received FDA clearance for its SkinPen® Precision microneedling device to treat neck wrinkles, expanding its indications beyond facial acne scars.
    • Q2 2024: Soliton Announces FDA Clearance of Rapid Acoustic Pulse Device for Cellulite Reduction Soliton, Inc. received FDA clearance for its Rapid Acoustic Pulse device, designed for the reduction in the appearance of cellulite, marking a new product entry in the U.S. medical aesthetics market.
    • Q3 2024: Alma Lasers Launches Alma TED™ Hair Restoration System in the United States Alma Lasers announced the U.S. launch of Alma TED™, a non-invasive ultrasound-based system for hair restoration, expanding its portfolio of energy-based aesthetic devices.
    • Q3 2024: Galderma Announces U.S. Launch of Restylane® Eyelight™ for the Treatment of Undereye Hollows Galderma launched Restylane® Eyelight™ in the U.S., a hyaluronic acid dermal filler specifically indicated for the treatment of undereye hollows.
    • Q3 2024: Sientra Files for Chapter 11 Bankruptcy Protection Sientra, a U.S. medical aesthetics company specializing in breast implants and body contouring, filed for Chapter 11 bankruptcy protection as it seeks to restructure its operations.
    • Q4 2024: Revance Therapeutics Announces FDA Approval of DAXXIFY® for the Treatment of Cervical Dystonia Revance Therapeutics received FDA approval for DAXXIFY® (daxibotulinumtoxinA-lanm) for the treatment of cervical dystonia, expanding its therapeutic indications in the U.S. market.
    • Q4 2024: Merz Aesthetics Launches Radiesse® (+) Lidocaine for Hand Augmentation in the U.S. Merz Aesthetics announced the U.S. launch of Radiesse® (+) Lidocaine, a dermal filler for hand augmentation to correct volume loss in the dorsum of the hands.
    • Q1 2025: Cutera Appoints New CEO to Lead Next Phase of Growth Cutera, a provider of energy-based aesthetic systems, appointed a new Chief Executive Officer to drive the company’s strategic growth initiatives in the U.S. medical aesthetics sector.
    • Q1 2025: Venus Concept Announces U.S. Launch of Venus Bliss Max™ for Non-Invasive Body Contouring Venus Concept launched Venus Bliss Max™ in the U.S., a new non-invasive device for body contouring and fat reduction, expanding its product offerings in the medical aesthetics market.
    • Q2 2025: Almirall Completes Acquisition of Bonti, Expanding U.S. Aesthetics Portfolio Almirall completed the acquisition of Bonti, a U.S.-based company focused on fast-acting neurotoxin treatments, strengthening its position in the U.S. medical aesthetics market.
    • Q2 2025: Cynosure Announces Opening of New U.S. Manufacturing Facility for Aesthetic Devices Cynosure opened a new manufacturing facility in the United States to increase production capacity for its portfolio of energy-based aesthetic devices.

    Market Segmentation

    US Medical Aesthetics Product Outlook

    • Facial Aesthetic Products
    • Cosmetics Implant
    • Skin Aesthetic Devices
    • Body Contouring Devices
    • Physician-dispensed Cosmeceuticals and Skin Lighteners
    • Hair Removal Devices
    • Tattoo Removal Devices
    • Thread Lift Products
    • Physician-dispensed Eyelash Products
    • Nail Treatment Laser Devices

    US Medical Aesthetics End User Outlook

    • Clinics, Hospitals, and Medical Spas
    • Beauty Centers
    • Home Care Settings
    • Q2 2024: Allergan Aesthetics Announces FDA Approval of Skinvive™ by JUVÉDERM® for the Improvement of Cheek Skin Smoothness in Adults Allergan Aesthetics, an AbbVie company, received FDA approval for Skinvive™ by JUVÉDERM®, a hyaluronic acid intradermal microdroplet injection, for improving cheek skin smoothness in adults.
    • Q2 2024: Crown Aesthetics Announces FDA Clearance of SkinPen® Precision for the Treatment of Neck Wrinkles Crown Aesthetics received FDA clearance for its SkinPen® Precision microneedling device to treat neck wrinkles, expanding its indications beyond facial acne scars.
    • Q2 2024: Soliton Announces FDA Clearance of Rapid Acoustic Pulse Device for Cellulite Reduction Soliton, Inc. received FDA clearance for its Rapid Acoustic Pulse device, designed for the reduction in the appearance of cellulite, marking a new product entry in the U.S. medical aesthetics market.
    • Q3 2024: Alma Lasers Launches Alma TED™ Hair Restoration System in the United States Alma Lasers announced the U.S. launch of Alma TED™, a non-invasive ultrasound-based system for hair restoration, expanding its portfolio of energy-based aesthetic devices.
    • Q3 2024: Galderma Announces U.S. Launch of Restylane® Eyelight™ for the Treatment of Undereye Hollows Galderma launched Restylane® Eyelight™ in the U.S., a hyaluronic acid dermal filler specifically indicated for the treatment of undereye hollows.
    • Q3 2024: Sientra Files for Chapter 11 Bankruptcy Protection Sientra, a U.S. medical aesthetics company specializing in breast implants and body contouring, filed for Chapter 11 bankruptcy protection as it seeks to restructure its operations.
    • Q4 2024: Revance Therapeutics Announces FDA Approval of DAXXIFY® for the Treatment of Cervical Dystonia Revance Therapeutics received FDA approval for DAXXIFY® (daxibotulinumtoxinA-lanm) for the treatment of cervical dystonia, expanding its therapeutic indications in the U.S. market.
    • Q4 2024: Merz Aesthetics Launches Radiesse® (+) Lidocaine for Hand Augmentation in the U.S. Merz Aesthetics announced the U.S. launch of Radiesse® (+) Lidocaine, a dermal filler for hand augmentation to correct volume loss in the dorsum of the hands.
    • Q1 2025: Cutera Appoints New CEO to Lead Next Phase of Growth Cutera, a provider of energy-based aesthetic systems, appointed a new Chief Executive Officer to drive the company’s strategic growth initiatives in the U.S. medical aesthetics sector.
    • Q1 2025: Venus Concept Announces U.S. Launch of Venus Bliss Max™ for Non-Invasive Body Contouring Venus Concept launched Venus Bliss Max™ in the U.S., a new non-invasive device for body contouring and fat reduction, expanding its product offerings in the medical aesthetics market.
    • Q2 2025: Almirall Completes Acquisition of Bonti, Expanding U.S. Aesthetics Portfolio Almirall completed the acquisition of Bonti, a U.S.-based company focused on fast-acting neurotoxin treatments, strengthening its position in the U.S. medical aesthetics market.
    • Q2 2025: Cynosure Announces Opening of New U.S. Manufacturing Facility for Aesthetic Devices Cynosure opened a new manufacturing facility in the United States to increase production capacity for its portfolio of energy-based aesthetic devices.

    US Medical Aesthetics Procedure Outlook

    • Breast Augmentation
    • Rhinoplasty
    • Facelift and Body Lift
    • Other Surgical Procedures

    Report Scope

    Report Attribute/Metric Details
    Market Size 2022 USD 2.5 Billion
    Market Size 2023 USD 2.71 Billion
    Market Size 2032 USD 5.209 Billion
    Compound Annual Growth Rate (CAGR) 8.50% (2023-2032)
    Base Year 2022
    Market Forecast Period 2023-2032
    Historical Data 2018- 2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, Procedure, End User, and Region
    Countries Covered US
    Key Companies Profiled AbbVie; Cynosure; Evolus Inc.; Revance Therapeutics, Inc; Galderma; Lumenis; Solta Medical; Syneron Candela; Alma Laser
    Key Market Opportunities ·       Growing incidence of obesity and heightened awareness of cosmetic procedures
    Key Market Dynamics ·       Increase in the number of cosmetic procedures that are non-invasive and low invasive

    FAQs

    How much is the medical aesthetics market?

    The US Medical Aesthetics market size was valued at USD 2.5 Billion in 2022.

    What is the growth rate of the medical aesthetics market?

    The market is projected to grow at a CAGR of 8.50% during the forecast period, 2023-2032.

    Who are the key players in the medical aesthetics market?

    The key players in the market are AbbVie; Cynosure; Evolus Inc.; Revance Therapeutics, Inc; Galderma; Lumenis; Solta Medical; Syneron Candela; Alma Laser.

    Which product led the medical aesthetics market?

    The facial aesthetic products category dominated the market in 2022.

    Which procedure had the largest market share in the medical aesthetics market?

    The non-surgical procedures category had the largest share in the market.

    What is the expected market size of the US Medical Aesthetics Market in 2024?

    The US Medical Aesthetics Market is expected to be valued at approximately 5.5 billion USD in 2024.

    What is the projected market size for the US Medical Aesthetics Market by 2035?

    The market is anticipated to reach around 14.0 billion USD by 2035.

    What is the expected compound annual growth rate (CAGR) for the US Medical Aesthetics Market from 2025 to 2035?

    The expected CAGR for the US Medical Aesthetics Market from 2025 to 2035 is approximately 8.865%.

    Which product segment in the US Medical Aesthetics Market is expected to have the largest value in 2024?

    The Facial Aesthetic segment is expected to hold the largest value at approximately 1.946 billion USD in 2024.

    What is the expected value of the Body Contouring Devices segment in the US Medical Aesthetics Market in 2035?

    The Body Contouring Devices segment is projected to be valued at around 3.111 billion USD by 2035.

    Who are the key players in the US Medical Aesthetics Market?

    Key players in the market include Sientra, Ipsen, Revance Therapeutics, Hugel, and CromaPharma among others.

    How much is the Cosmetic Implants segment valued at in 2024 within the US Medical Aesthetics Market?

    The Cosmetic Implants segment is valued at approximately 0.846 billion USD in 2024.

    What market growth rate is anticipated for Hair Removal Devices from 2025 to 2035?

    The Hair Removal Devices segment is expected to witness significant growth during the period with a market value of around 1.944 billion USD in 2035.

    What are the growth opportunities in the US Medical Aesthetics Market?

    Growth opportunities in the market stem from increasing consumer awareness and technological advancements in aesthetic treatments.

    What is the estimated market value for Skin Aesthetic Devices in 2035?

    The Skin Aesthetic Devices segment is projected to reach a value of approximately 2.178 billion USD by 2035.

    What is the expected market size of the US Medical Aesthetics Market by 2024?

    The US Medical Aesthetics Market is expected to be valued at 5.5 billion USD by the year 2024.

    How much is the US Medical Aesthetics Market projected to grow by 2035?

    By 2035, the market is projected to reach a value of 14.0 billion USD.

    What is the anticipated compound annual growth rate (CAGR) for the US Medical Aesthetics Market from 2025 to 2035?

    The CAGR for the US Medical Aesthetics Market is expected to be 8.865% from 2025 to 2035.

    Which product segment is expected to dominate the US Medical Aesthetics Market in 2024?

    The Facial Aesthetic segment is expected to dominate the market with a value of 2.1 billion USD in 2024.

    What will be the market size for Body Contouring Devices by 2035?

    The Body Contouring Devices segment is projected to reach a value of 3.4 billion USD by 2035.

    What will the market size for Cosmetic Implants be in 2024?

    In 2024, the market size for Cosmetic Implants is expected to be valued at 1.0 billion USD.

    What is the projected market size for Hair Removal Devices by 2035?

    The Hair Removal Devices segment is projected to grow to 1.9 billion USD by 2035.

    What are some growth drivers for the US Medical Aesthetics Market?

    Factors such as increased consumer demand for aesthetic procedures and advancements in technology are key growth drivers.

    What is the expected value of the Skin Aesthetic Devices segment by 2035?

    The Skin Aesthetic Devices segment is expected to be valued at 1.0 billion USD by 2035.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials